FAK-mediated Inhibition of Vascular Smooth Muscle Cell Migration by the Tetraspanin CD9
- 1 January 2002
- journal article
- review article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 87 (06) , 1043-1050
Abstract
Migration of vascular smooth muscle cells (SMC) towards the intima is a key event in vascular proliferative diseases. We investigated a potential role for the tetraspanin CD9 in this process in a wound migration assay. Aortic SMC from CD9 knock-out mice had higher migration rates and the presumably stimulatory anti-CD9 antibody ALMA-1 inhibited migration of human SMC. The signaling pathways responsible for this inhibitory effect were investigated. In migrating CD9−/− SMC, stress fiber formation was decreased and focal adhesions were smaller and more diffusely distributed, consistent with an inhibition of integrin clustering. In migrating mouse SMC expressing CD9, focal adhesion kinase (FAK) tyrosine phosphorylation was doubled. No differences in intracellular calcium signaling were observed between CD9+/+ and CD9−/− SMC during migration. We suggest that CD9 inhibits SMC migration by a stimulation of both stress fiber formation and integrin clustering, leading to a stimulation of FAK phosphorylation. * Present address: Friedrich Miescher Institute for Biomedical Research, Maulbeerstraße 66, CH-4058 Basel, SwitzerlandKeywords
This publication has 18 references indexed in Scilit:
- Tetraspanins2002
- CD9 Participates in Endothelial Cell Migration During In Vitro Wound RepairArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Tetraspanin CD9 Is Associated With Very Late–Acting Integrins in Human Vascular Smooth Muscle Cells and Modulates Collagen Matrix ReorganizationArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- The tetraspanin superfamily: molecular facilitatorsThe FASEB Journal, 1997
- Association of TM4SF proteins with integrins: relevance to cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1996
- Is vascular smooth muscle cell proliferation beneficial?The Lancet, 1996
- CD9 plays a role in Schwann cell migration in vitroJournal of Neuroscience, 1995
- CD9 antigen is an accessory subunit of the VLA integrin complexesEuropean Journal of Immunology, 1994
- Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA.Journal of Experimental Medicine, 1993
- Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility.Journal of Experimental Medicine, 1991